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Annexins are a family of calcium- and phospholipid-binding proteins found in nearly all eukaryotes. They are structurally highly
conserved and have been implicated in a wide range of cellular activities. In this paper, we focus on Annexin A2 (AnxA2). Altered
expression of this protein has been identified in a wide variety of cancers, has also been found on the HIV particle, and has been
implicated in the maturation of the virus. Recently, it has also been shown to have an important role in the establishment of normal
apical polarity in epithelial cells. We synthesize here the known biochemical properties of this protein and the extensive literature
concerning its involvement in the endocytic pathway. We stress the importance of AnxA2 as a platform for actin remodeling in
the vicinity of dynamic cellular membranes, in the hope that this may shed light on the normal functions of the protein and its
contribution to disease.
1. The Annexins
A number of reviews have already been written on this
large family of proteins. For the sake of brevity, we can
only cursorily describe these roles. The annexins are found
in all multicellular and some single-cell eukaryotes. They
are a highly conserved family of calcium and phospholipid-
binding proteins usually comprising four repeats of the
characteristic alpha-helical-rich endonexin fold and an N-
terminal domain that is unique to each annexin [1–5], Figure
1. Individual annexins tend to show restricted expression in
particular cell types, the so-called “annexin fingerprint”, and
where they are expressed; they tend to be highly abundant.
In diﬀerent phyla, they have evolved to perform a
variety of cellular functions but all retain a set of core
properties [2–7]. They bind dibasic metal ions (usually
calcium) and associate with charged phospholipids. They
sometimes form oligomers, which can associate into high-
order pseudocrystalline arrays on the surface of membranes,
somewhat reminiscent of viral capsids [1]. In other cases,
they have been suggested to insert into membranes, poten-
tially forming pores or indeed to pass through the membrane
entirely to act as an extracellular protein, with functions that
may have little to do with their intracellular roles. Mem-
brane association is dependent upon lipid content, calcium
concentration, pH, and secondary modifications such as
phosphorylation/myristoylation and their associations with
a wide selection of binding partners [1, 2].
In the most general terms, they have been implicated in
calcium sensing and homeostasis [8–10], pH sensing [11],
actin binding and regulation [12, 13], cell signaling [14–16],
and fibrin homeostasis [17–20]. This list is far from being
complete and individual annexins may have overlapping or
shared functions.
Changes in their expression levels have been impli-
cated in a number of human diseases, loosely termed
“annexinopathies” (reviewed in [21–24]). In most cases, the
role of the annexin in pathogenesis has been linked to a
well-characterized extracellular function of the protein, for
instance, as a viral receptor [25], in regulation of fibrin [17–
20] or in autoimmune disease [25]. However, intracellular
functions of the proteins are likely to be at least as important,
for instance in their role in mineralization of bone and car-
tilage for example [26, 27] or in tumour development [28].
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Figure 1: Structure of AnxA2. (a) Space filling view of AnxA2 (colours indicate hydrophobicity) looking “down” onto the membrane-
binding surface of the molecule. One endonexin fold, repeated four times in AnxA2, is highlighted in yellow. (b) “Cartoon” of AnxA2
showing the molecule from the side. The protein is almost entirely made up of alpha-helices. The position of coordinated calcium atoms is
shown in green.
In this paper, we shall concentrate on Annexin A2
(AnxA2), which, whilst being an archetypal annexin, has
a number of distinct properties rendering it particularly
apposite to regulate actin-associated cellular processes at
dynamic membranes.
Importantly, of all the annexins, altered expression of
AnxA2 is most correlated with disease progression. The
protein has been found on the HIV particle and has been
implicated in the maturation of the virus [29, 30]. Further-
more, it is been linked to carcinogenesis and the progression
of invasive cancer [23, 24, 28], suggesting an AnxA2-specific
function that is necessary for tumour development. Indeed,
AnxA2 was first identified as a major substrate of the tyrosine
kinase v-Src, the transforming gene product of the Rous
sarcoma virus [31–34].
1.1. Membrane Recruitment of AnxA2. AnxA2 diﬀers from
other annexins in that its association to membranes is
most sensitive to increasing calcium levels (only requiring
0.05 µM calcium to drive membrane association) [9] and
structurally, in that it has a unique and relatively short
36 aminoacid N-terminal domain. AnxA2 is mostly found
in a stable heterotetramer with S100A10, a small, EF-hand
protein that is unique within its own family in being able
to bind calcium. This complex, consisting of two S100A10
and two AnxA2 molecules [34–36], has a higher aﬃnity for
calcium and phospholipid than the AnxA2 monomer alone
[34] and is found associated with the cytoplasmic leaflet of
the plasma membrane and specific membrane-bound struc-
tures, such as endosomes and transport intermediates [36,
37]. Ionophores and extracellular ligands which cause influx
of calcium further recruit the AnxA2-S100A10 complex to
these membrane sites, although it often remains associated
with these membrane domains after the initial calcium pulse
has subsided (our unpublished observations). This suggests
that the initial calcium-dependent recruitment is followed
by stabilization; either by protein-protein or protein-lipid
interactions. This most likely includes association with the
submembranous actin cytoskeleton known to be present on
endosomes and the plasma membrane [38, 39].
AnxA2 has been shown to favour cholesterol-rich sub-
domains of membranes [40], suggesting a predilection for
regions of themembrane with reduced fluidity. Furthermore,
in vitro, AnxA2 seems to have aﬃnity for most anionic
phospholipids and displays a calcium-enhanced aﬃnity for
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) [41–44],
a lipid enriched at the plasmamembrane and vesicles derived
from it. This lipid preference is in line with its cellular
location (exclusion from membranes of the endoplasmic
reticulum, Golgi, mitochondria) and in association with the
plasma membrane (in particular to the apical membrane
in polarized cells) and specific membrane-bound compart-
ments.
Accordingly, in cells lacking the inositol polyphos-
phate 5′-phosphatase OCRL1 (which has a preference
for PI(4,5)P2, but also acts upon PI(3,4,5)P3), AnxA2 is
recruited to vesicular structures that contain presumed
PI(4,5)P2 accumulations [42, 45, 46]. These structures, so-
called “rockets”, are highly motile; being driven around the
cell by a rapidly growing, arborescent actin tail (sometimes
called an actin comet) and are richly decorated with AnxA2.
Depletion of AnxA2 or inhibition of PI(4,5)P2 production in
cells lacking OCRL1 blocks the formation of these rockets.
This observation demonstrates the properties we believe
AnxA2 is critical for, that is, the remodeling of actin driving
membrane rearrangements.
1.2. Annexin A2 and Actin. The ability of the AnxA2 and
the AnxA2-S100A10 tetrameric complex to bind and bundle
filamentous actin (F-actin) was first identified using proteins
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purified from the brush-borders of porcine epithelial cells
[47] and from A431 cells [48]. The aﬃnity of AnxA2 for
actin and its requirement for calcium was further refined
using protein purified from bovine lung [49] and a putative
actin-binding nona-peptide was identified in the C-terminus
of the protein [50]. The tetrameric complex is able to
bundle F-actin at near physiological calcium concentrations
(0.5 µM calcium) and gives rise to a 1 : 1.9 stoichiometry of
annexin bound to actin. Interestingly, the bundling activity
of the tetrameric complex was found to be decreased by
phosphorylation of the protein on Tyr23, the site favoured
by the tyrosine kinase Src, suggesting a possible role for Src
in the association of AnxA2 with actin [51].
At micromolar calcium concentrations in vitro, the
AnxA2 monomer alone (without associated S100A10) is able
to “cap” the fast-growing “barbed” end of the growing actin
filament and possibly also interacts directly with G-actin
monomers. Thus, AnxA2monomer not only has the capacity
to bundle preformed filaments, but may regulate the growth
of newly forming ones [52].
Whilst the protein may perform this bundling and
bridging function we suspect it is not its primary function.
Accordingly, AnxA2 is not usually seen “coating” large actin
bundles, such as stress-fibres and filopodia, as would be
expected for a conventional actin bundling protein. Instead,
AnxA2 is likely to have a more precise role in regulating actin
cytoskeletal rearrangements. Consistently, in vivo, AnxA2
localises to regions of free-barbed ends (identified with
labeled monomeric actin units) [52].
Taken together, we propose that AnxA2 functions at sites
of actin association with membranes enriched in cholesterol
and/or phosphoinositides. Supporting this proposal, AnxA2
has been shown to have roles in many steps of membrane
traﬃcking and cell polarity. This is reviewed below (also see
Figure 2).
2. AnxA2 and Membrane Traffic
2.1. Formation and Dynamics of Macropinosomes. A number
of annexins have been implicated in vesicular traﬃck-
ing events [53]. A particular function for AnxA2 at the
interface of membrane and actin was fully established
when it was shown to be required for the rocketing of
macropinosomes [54]. These are large vesicles formed by the
closure of dynamically ruﬄing plasma membrane. Although
the physiological significance of these objects is debatable,
they are likely to be formed by all motile cells (such
as macrophages and fibroblasts) and are involved in the
process of integrin recycling [55]. Macropinosomes are also
formed by professional antigen-presenting cells, which utilise
them to sample the extracellular milieu and as a route of
entry for a number of viruses. They are produced under
a number of diﬀerent experimental conditions, including
the constitutive activation of the small GTPase Rac [56],
activation of tyrosine kinase Src [57], or under general
enhanced tyrosine and serine phosphorylation (with the use
of phosphatase inhibitors) [54]. They also appear under con-
ditions of elevated PI(4,5)P2 production, for example upon
phosphatidylinositol 4-5 kinase overexpression or OCRL1
depletion.
Although AnxA2 is particularly enriched at the junction
between the vesicle and the actin, the exact role of AnxA2 in
this process is yet to be established. It may act as a barbed-
end capping protein, consistent with its enrichment near the
vesicle (the site of much of the de novo actin polymerization).
It may partially restrict the spread and growth of the actin
on the comet, to optimize its motility (capping adventitious
filaments as they spread from the sides of the actin tail).
Alternatively, it may act as a bridge, physically linking the
actin to the membrane (a property we have identified for the
recombinant protein in vitro [42]) or as a bundling protein
promoting the condensation of a diﬀuse actin “halo” into a
discrete tail.
2.2. Phagocytosis. AnxA2 has also been implicated in the
phagocytic process. It accumulates on actin-rich phagosomes
produced when outer segments (the eﬀete part of the pho-
toreceptor) are internalized by retinal pigmented epithelial
cells, and are lost from the phagosome at the same time as
the actin which drives internalization. During phagocytosis,
AnxA2 is tyrosine phosphorylated, possibly by Src that is
also recruited to the phagocytic cup, suggesting a role for
Src-mediated AnxA2 phosphorylation in regulation of the
process. Accordingly, depletion of AnxA2 from these cells
resulted in slower kinetics of phagocytosis in tissue culture,
and AnxA2 knock-out mice show similarly altered kinetics
of phagosome degradation [58]. Recently, other annexins
including AnxA1 (the most closely related annexin to
AnxA2) have also been shown to be involved in phagocytosis
and in linking actin to the phagosome [59]. However, a role
for the PI(4,5)P2-binding function of AnxA2 in this process
has not been ascribed.
2.3. Endocytosis
2.3.1. Budding of Clathrin-Coated Vesicles. Annexins have
also been shown to be involved in the first step of endocyto-
sis, that is, the formation and pinching oﬀ of clathrin-coated
vesicles (CCVs). AnxA2 and AnxA6 were first reported on
CCVs in the adrenal gland [60]. Association of AnxA2 to
these CCVs may be direct through interaction with the µ2
subunit of the AP-2 clathrin adaptor complex (identified
by two hybrid screening [61]). AP2 is proposed to mediate
internalization from the plasma membrane by linking inter-
nalizing receptors and cargo to the clathrin coat. µ2 binds to
the YXX∅ cytoplasmic domain of transmembrane receptors
and AnxA2 has two of these domains in its N-terminus.
Furthermore, as the interaction between µ2 and YXX∅motif
of the receptors has been shown to be mediated by PI(4,5)P2
[62], we propose that it may also be the case for AnxA2
given its ability to bind PI(4,5)P2 directly. What importance
might AnxA2 have in this event? Actin polymerization has
been proposed to transiently occur on invaginating CCVs
as they internalize and AnxA2 might help in mediating this
transient burst of polymerization. In agreement with this,
when AnxA2 is depleted from cells, grape-like clusters of
clathrin-coated vesicles are observed [63], suggesting a role
for the protein in their budding.
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Figure 2: Recruitment of AnxA2 to several sites in the endocytic pathway. AnxA2 is shown as little green structures, filamentous actin as
wavy lines, and Src is represented as orange diamonds. EPEC: Association with the actin-rich pedestals of noninvasive enteropathogenic
E.coli. Phagosome: AnxA2 is recruited to actin-rich phagosomes during pigmented retinal epithelial cell phagocytosis of rod outer segments.
Macropinosome: AnxA2 is recruited to PI(4,5)P2-rich (purple shading) macropinosomes and is absolutely required for their actin-based
rocketing (Comet). Macropinosomes or other early endosomes may mature into APPL2/OCRL1-positive early endosomes. These in turn
mature into EEA1-positive endosomes. Endocytic traﬃcking appears to be involved in formation and reformation of the adherens junction
(AJ) and extracellular AnxA2/S110A10 complex, which may be released in exosomes when multivesicular late endosomes (MVBs) fuse with
the plasma membrane that may contribute to tight junction stability by cross-linking adjacent membranes. The role of AnxA2 in formation
of the apical domain is more speculative but may involve formation of a preformed vacuolar apical compartment (VAC), which then may
fuse with the apical surface.
2.3.2. Localization/Positioning of Early and Recycling Endo-
somes. The first evidence that AnxA2 had a broader role in
the endocytic pathway comes from observations by Harder
and Gerke and Jost et al., [40, 64] identifying an association
of AnxA2 with early endosomes in polarized epithelial cells
(Madin-Darby canine kidney cells: MDCK cells). Further-
more, when a chimeric AnxA2/S100A10 fusion protein was
introduced into the cells (which caused the aggregation of
AnxA2), early endosomes were also aggregated.
AnxA2 association with early endosomes is suggested
to be predominantly mediated by its association with
cholesterol-rich domains [39]. Indeed, in cells in which
cholesterol traﬃcking is blocked, AnxA2 accumulates on late
endosomes and lysosomes (e.g., in Niemann-Pick fibrob-
lasts). This binding was independent of S100A10, indicating
that the cholesterol-dependent association of AnxA2 with
endosomes does not require formation of the tetrameric
complex. However, although the authors of these studies
demonstrate continued traﬃcking of other cargos, gross
changes to the traﬃcking of cholesterol may have unforeseen
consequences for the entire endocytic pathway.
Binding of AnxA2 to endosomes influences their local-
ization. When a chimeric AnxA2/S100A10 fusion protein is
introduced into cells (which causes aggregation of AnxA2),
early endosomes are also aggregated. Depleting Anx2A also
leads to a dramatic change in the general distribution and
morphology of early and recycling endosomes that collapse
into a perinuclear domain. Furthermore, the tubules of these
endosomes become tortuous and bent [63, 64].
Both early and late endosomes have been shown to be
actin positive, and AnxA2 has been implicated in regulating
this actin [65]. It is tempting to speculate that AnxA2-
mediated actin remodeling could have a role to play in
maintenance of the architecture and positioning of the
recycling endosome. Interestingly, this function is supported
by a partial colocalization of AnxA2 with Rab11a (a marker
of the recycling endosome) in cells transformed by the
oncogene v-Src [66].
2.3.3. Early-to-Late Endosome Maturation. The first indi-
cation that AnxA2 was involved in endosomal function
came from studies using endosome fusion assays. Indeed, a
subtle reduction in endosome fusion mediated by AnxA2-
free cytoplasm was noted that was rescued by addition of
recombinant protein. Furthermore, HeLa cells depleted of
AnxA2 by RNA interference show reduced transfer of a fluid-
phase marker of endocytosis and of EGF, to the lysosome, but
not internalized LDL [67], suggesting that AnxA2 displays a
specific role in traﬃcking a subset of cargoes.
Conversely, recycling of transferrin receptor is unaﬀected
by AnxA2 loss, suggesting that the protein is involved
specifically in maturation of late endosomes [68].
Failure of late endosome maturation could be rescued
by a pseudotyrosine-phosphorylated AnxA2 construct but
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not by a mutant in which the phosphorylation site was
mutated [69]. This strongly implicates a role for tyrosine
phosphorylation (perhaps by a Src-kinase family member)
in regulating AnxA2 function during early-to-late endosome
maturation, analogous to the function we propose for AnxA2
in the conversion of APPL endosomes to EEA1 endosomes.
In this respect, Morel et al., [65, 69] recently described
dynamic patches of short actin filaments on a subset of both
early and late endosomes and crucially, AnxA2 has been
shown to be required for formation of these actin patches,
as were the actin nucleating proteins Arp2/3 and Spire1. In
cells depleted of AnxA2, late endosomes remained intimately
associated with the vesiculotubular early endosome. This
suggests that AnxA2-mediated actin polymerization may
drive a scission event which is in line with a requirement of
actin polymerization in the eﬃcient maturation from early
to late endosome.
On a speculative note, Anx2 could also have a role
in early endosomal conversion. By this, we refer to the
existence of a pool of APPL/Rab5-positive but EEA1/PI3P-
negative early endosomes that acquire PI3P and EEA1. APPL
endosomes are derived from both macropinosomes and a
subset of vesicles formed by clathrin-mediated endocytosis
and represent a very early stage in the endocytic cycle,
lying upstream of the canonical PI(3)P-positive endosomes
[70–72]. The distribution of AnxA2 to early endosomes
identified by flotation fractionation closely mirrors that of
APPL1/2. Furthermore, AnxA2 and APPL1/2 colocalise in
vivo. Depletion of AnxA2 resulted in reduced formation
of APPL-positive endosomes and solubilisation of APPL2
protein. This suggests that AnxA2 plays a key role in the
identity and/or formation of APPL-endosomes and warrants
further investigation.
Interestingly, APPL proteins physically interact with
OCRL1, which is recruited to the CCV after the scis-
sion event [73]. This suggests that some function of
APPL-endosomes is regulated by dynamic changes in
PI(4,5)P2 and/or PI(3,4,5)P3 levels. A negative feedback
loop could be envisaged, in which recruitment of AnxA2 to
PI(4,5)P2/PI(3,4,5)P3-rich endosomal structures (probably
in association with clathrin), is followed by subsequent
recruitment of APPL1/2 and OCRL1. The presence of
OCRL1 would deplete the early endosome of these phos-
phoinositides and release AnxA2 and APPL1/2, allowing
the endosome to mature towards an EEA1-, PI(3)P-positive
fate. This refinement, though extremely speculative, may
explain the sometimes-contradictory results reported in
the literature and is the subject of ongoing study in our
laboratory and others.
3. AnxA2 and Epithelial Polarity
The second critical function for AnxA2 that engages both
its biochemical properties is exemplified by its role in the
establishment of epithelial polarity. In response to signals
from the external environment, epithelial cells polarize their
membrane domains into distinct apical and basolateral
domains, separated by intercellular contacts such as adherens
and tight junctions. AnxA2 is able to recruit and potentially
activate Rho GTPases as well as key polarity complexes
which act in concert to orchestrate the actin cytoskeletal
rearrangements required for epithelial polarity. Although
some links are yet to be clarified, it is apparent that AnxA2
is a central player in the genesis of epithelial cell polarity.
3.1. Annexin A2 Is a Key Orchestrator of Cell-Cell Adhesion
through Actin Remodeling. Cell-cell adhesion is strongly
regulated by the activities of Rho GTPases and their eﬀects
in regulation of the actin cytoskeleton [74, 75]. This requires
a balancing act between the diﬀerent activities of the
Rho GTPases, and AnxA2 has been shown to control the
localization and activation state of a number of these.
On one hand, AnxA2 recruits Rho to the plasma
membrane, for instance in wound closure assays in Caco-
2 epithelial cells which facilitates cell motility/migration, a
process antagonistic to cell junction formation. Correspond-
ingly, in cells in which AnxA2 is depleted, Rho recruitment
to lamellipods is decreased and cells fail to migrate [76].
On the other hand, during the initial stages of cell-cell
adhesion, another Rho GTPase, Rac1, becomes localized to
nascent junctions, driven by an interaction with E-cadherin
[77]. Interestingly, this recruitment of Rac1 is dependent
upon AnxA2. The recruitment of AnxA2 to junctions
is dependent on PI3K activity, which is consistent with
the reported complex between AnxA2 and the regulatory
subunit of PI3K [78]. AnxA2 may be recruited to the plasma
membrane at sites of nascent junction formation through
binding to PI3K directly or by binding to PI(3,4,5)P3, which
is in contrast to what is generally assumed to be its preferred
phosphoinositide, PI(4,5)P2. It is noteworthy to mention
that AnxA2 harbors binding aﬃnity for PI(3,4,5)P3, albeit
weaker than that for PI(4,5)P2 [41, 43].
AnxA2 has also been shown to regulate the actin
cytoskeleton via its interaction with the scaﬀold protein,
AHNAK (also known as Desmoyokin) [79, 80] which
recruited to cholesterol-rich domains of the plasma mem-
brane in an AnxA2-dependent manner. Upon depletion of
AnxA2 actin cytoskeleton fails to remodel and epithelial cells
cannot mature from a flattened cell state to a characteristic
tall columnar state. Depletion of AHNAK alone leads to
the same, or at least a very similar, phenotype as AnxA2
depletion.
3.2. AnxA2 Is Required for Adherens Junction Formation. A
second critical role for AnxA2 in cell polarity is in the
formation of E-cadherin-based adhesions downstream of
Nectin-1. In a so-called “calcium switch”-experiment in
which cell-cell contacts are disassembled and then can be
observed as they are rebuilt over time, rerecruitment of
E-cadherin to junctions fails in cells depleted of AnxA2.
Despite the lack of E-cadherin targeting, the tight junction
still is formed in these cells [81]. This clearly indicates
that AnxA2 has a key role in the establishment of E-
cadherin-based adherens junctions but not tight junctions.
These data place AnxA2 at the heart of nascent E-cadherin-
based adhesions, which are critical to the underlying actin
cytoskeletal network of epithelial cells.
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The role of AnxA2 is not limited to epithelial, but also
endothelial cells. AnxA2 has been shown to play a key role in
the structure of endothelial adherens junctions and associates
with VE-cadherin [82, 83]. Depletion of AnxA2 results in the
loss of VE-cadherin from junctions leading to subsequent
adherens junction instability. Endothelial morphogenesis is
severely disrupted in these cells, due to inhibition of an AKT
signaling pathway downstream of the adherens junction [82].
In addition, VEGF treatment destabilizes the interaction
between AnxA2 and VE-cad and results in subsequent loss
of junctional integrity. This may seem inconsistent with
the apparently normal vasculature of the AnxA2 knock-out
mouse, suggesting a redundancy in vascular development
that ensures the proper formation of junctions even in
the absence of AnxA2. The AnxA2 knock-out mouse does,
however, demonstrate defects in neoangiogenesis [18], a
related process that provides tumours with the necessary
blood flow for growth. Indeed, AnxA2 KOmice are incapable
of supporting the growth of solid tumours in an implan-
tation assay, consistent with a role for AnxA2 in tumour
progression.
3.3. 3D Cysts Reveal a Key Contribution of AnxA2 in the Estab-
lishment of Epithelial Organs. As described above, AnxA2
functions as an initiator of actin remodeling events and does
so through the integration of spatiotemporal modulations
of phosphoinositides and the recruitment and/or activation
of Rho GTPases. In addition, use of 3D MDCK cysts reveal
key findings that depletion of AnxA2 or overexpression of
dominant negative AnxA2 prevents the formation of the
central lumen [84]. AnxA2 is thought to influence this
process on two critical sites: at Rab11a-positive recycling
endosomes and at the plasma membrane.
3.3.1. A Role for AnxA2 at Rab11a Endosomes in Lumen
Formation. Rab11a recycling endosomes are now recognized
as a key intermediate in the traﬃcking of junctional
proteins, such as E-cadherin, to the plasma membrane
[85–87]. AnxA2 transiently localizes to Rab11a endo-
somes that in epithelial cells contain the apical marker
GP135/podocalyxin, prior to lumen formation [87, 88].
Overexpression of a dominant negative form of AnxA2 leads
to defects in the development of the lumen that coincides
with the accumulation of GP135 in Rab11a endosomes,
suggesting that AnxA2 plays a key role in the delivery of
this marker from a “recycling compartment” to the plasma
membrane. It appears that AnxA2 has a role in GP135
recycling in spite of having no obvious eﬀect on transferrin
recycling (see Section 2.3). This may reflect specific functions
related to cell types and cargo.
3.3.2. Annexin A2 and Polarized Plasma Membrane Domains.
In addition to recycling of apical markers, AnxA2 plays a
key role at polarized plasma membrane domains. During
the formation of 3D MDCK cysts, prior to lumenogenesis,
PI(3,4,5)P3 is enriched at the plasma membrane, relative
to PI(4,5)P2 [84, 89]. At that stage, AnxA2 localizes to the
plasma membrane, perhaps through a weak interaction with
PI(3,4,5)P3 [44].
Vital to the formation of a lumen is the activity of the
inositol lipid 3′-phosphatase PTEN, which is recruited to
the presumptive apical surface where it generates PI(4,5)P2
which AnxA2 binds to with a higher aﬃnity. Upon gener-
ation of PI(4,5)P2 at apical membranes by PTEN, AnxA2
shifts its localization to sites at which its preferred substrate
is concentrated [84].
AnxA2 binding to PI(4,5)P2 at the apical surface initi-
ates a cascade of events vital to epithelial morphogenesis.
For instance, AnxA2 is proposed to recruit another Rho-
subfamily member, Cdc42, and the key polarity proteins
aPKC and Par6 to the nascent apical surface [84, 88].
Although it seems most likely that AnxA2 functions
to scaﬀold active Cdc42 and nucleate actin remodeling,
it is also highly possible that the formation of the apical
surface requires the fusion of small vesicles enriched with
AnxA2. Interestingly, Cdc42 is required for TGN exit of
basolateral proteins [90] and AnxA2 has been detected
in TGN-derived apically targeted vesicles in MDCK cells.
In this context, downregulation of AnxA2 in MDCK cells
specifically interferes with the routing of vesicles to the apical
plasma membrane [91]. This has also been demonstrated
in Caco-2 cells, in which depletion of AnxA2 leads to a
strong polarization defect, characterized by a morphological
transition to flat, undiﬀerentiated epithelial cells with sparse
and short microvilli and reduced levels of brush border
proteins [92]. Interestingly, myristoylated annexin XIIIB has
also been shown to be essential for apical delivery of such
vesicles and revealed to be vital to 3D cyst formation [93–
95]. This may explain why the phenotype of AnxA2 RNAi
in cysts is not as penetrant as overexpression of dominant
negative forms of it or as dramatic as depletions of other
molecular components required for cyst formation such as
Cdc42, aPKC, the exocyst, and PTEN.
3.4. A Role for Extracellular AnxA2 in Cell-Cell Adhesion.
Not only AnxA2 is expressed at particularly high levels in
epithelia and endothelia intracellularly, but it also appears
as an extracellular, cell-surface-associated pool in complex
with S100A10. How the tetrameric complex exits cells to
appear on the outer leaflet has also been a subject of
much discussion. As a protein lacking a signal peptide,
AnxA2 is one of a growing list of unconventionally secreted
proteins [96–98], which could occur by one of three ways.
The first is by incorporation into intraluminal vesicles
of multivesicular endosomes and subsequent release as
exosomes [99]. This process is promoted by interaction
with S100A10 and by phosphorylation at Tyr23 [100]. The
second emanates from a study of the short-lived cells of
the enterocyte brush border, which are covered in AnxA2
on their luminal, microvillus-decorated surface [101]. In
these cells, AnxA2 nonconventional secretion is proposed
to involve an intimate association with SNARE proteins at
sites of endosome/plasma membrane fusion. This suggests
that SNARE-mediated fusion of the membranes forces the
annexin complex across the membrane and out of the cell.
The third would be similar to what has been shown for
another unconventionally secreted protein, FGF-2, whereby
it exits cells by forming a transmembrane channel or pore
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[98]. Interestingly, this pore formation is strongly regulated
by the presence of PI(4,5)P2 at the plasma membrane, a
feature that fits the biochemical properties of AnxA2.
Whichever the means of cell egress, extracellular AnxA2
has been implicated in in membrane bridging [102, 103]
and tight junction formation [104] and may represent an
additional mode of regulating epithelial morphogenesis to
that we described earlier in Section 3.
Tetrameric AnxA2 complex colocalises with tight junc-
tion markers along the lateral plasma membrane and a
pool of this protein was shown to be extracellular. Addi-
tion of an inhibitory peptide (aimed at interrupting the
AnxA2/S100A10 complex formation) across a calcium switch
experiment blocked tight junction reformation, consistent
with the idea that extracellular AnxA2 plays an important
role in remodeling of tight junctions [104].
Phosphorylation of AnxA2 on Tyr23 leads to its increased
recruitment to the plasma membrane and subsequently to
sites of actin remodeling [105]. Given that it also promotes
AnxA2 secretion, it would be of interest to analyze the
relative contribution of this secreted AnxA2 on MDCK
cell scattering, in comparison to the known intracellular
functions of AnxA2.
4. Discussion
The principal biochemical properties of AnxA2 are calcium-
dependent association with phospholipids and actin. These
properties have now been refined both in vitro and in
vivo at physiologically significant calcium concentrations to
an aﬃnity for PI(4,5)P2-, PI(3,4,5)P3- and/or cholesterol-
containing membranes and the ability to cap the fast-
growing ends of actin filaments. These are subtle but
important refinements because they change the role of the
protein from being that of a structural “contaminant” of
membrane and cytoskeletal preparations to being critical in
establishing a specific subset of membrane-actin interfaces.
It may be the case that the annexin itself is suﬃcient to
form this structure but it is likely that in vivo a number
of annexin/actin/PI(4,5)P2-associated proteins ultimately
bulwark the membrane/actin interface.
In this paper, we have outlined the predominant role
of AnxA2 in events that occur in the vicinity of the
plasma membrane including clathrin-mediated budding,
formation of macropinosomes and phagosomes, conversion
of early endosomes and maturation of early-to-late endo-
somes (depicted in Figure 2). AnxA2 is also important for
secretory events, such as granule secretion. Furthermore, the
formation of the apical domain and cell-cell junctions in
polarized cells is also highly dependent upon AnxA2.
AnxA2 may mediate these events (almost all of which
are mediated by PI(4,5)P2 and calcium) either as a result
of its inherent biological activity or indirectly through its
interactome (e.g., the recruitment of small Rho GTPases
or potential interactions with actin/lipid metabolizing pro-
teins). The potential role for AnxA2 at recycling endo-
some events and during endosome-maturation is less well
established and may be a cholesterol-mediated function or
occur under specific conditions, such as when the protein
is hyper-phosphorylated, for example during Src-mediated
transformation.
Almost all these processes occur concomitantly with
significant actin remodeling. This may be necessary to drive
vesicle motility or to ease endosome movement through
dense cortical actin filaments. However, the importance of
short bursts of actin polymerization during vesicle fusion
and fission is controversial and is less well understood with
regard to the maintenance of endosomal structure.
In the formation and motility of actin rockets and
macropinosomes and in 3D epithelial polarity, both lipid and
actin binding properties of AnxA2 have been implicated. In
other events linked to AnxA2, only one of its biochemical
properties has so far been involved. For instance, in our
proposed model of early endosome transition, processes of
CCV formation, and granule secretion, there is clearly a
role for PI(4,5)P2 dynamics; but a role for actin is less
well established. Conversely, the maturation of early-to-late
endosomes requires AnxA2-mediated actin polymerization,
but a role for PI(4,5)P2 regulation of AnxA2 in this process
is still to be demonstrated. There is clearly room for further
investigations of the link between the two biochemical
properties of AnxA2 in these processes.
AnxA2 is highly abundant in those cells in which it is
expressed; but it is not ubiquitous. For this reason, it cannot
be critical in all cell types for all the processes we have
described in this paper. This may be partly explained by the
potential redundancy between annexin family members that
due to space limitation, we have not been able to discuss.
The Annexin family is highly conserved and many of the
other members, in spite of having unique sequences (e.g.,
in their N-termini) have shared biochemical activities with
AnxA2. Individual lipid/calcium/actin-binding aﬃnities and
specificities may vary, but the potential for overlap is clear.
Indeed, in many cases, they have been implicated in related
processes and may form oligomeric complexes; though as
yet overexpression of one family member has not been
shown to compensate for loss of another. This may explain
the viability and fertility of the AnxA2 knockout mouse.
Notwithstanding homeostatic alterations in annexin or other
gene expression which may compensate for genetic lesion,
the mouse does seem surprisingly healthy given the number
of processes in which AnxA2 has been implicated. It appears
that the major defects in the mouse are not in normal
development; but rather in subsequent plastic changes: the
mouse seems to be incapable of sustaining neovasculari-
sation, for example, which may make AnxA2 a promising
target for drug intervention in cancer treatment. Inherent
redundancies in endocytosis, phagocytosis, and junction
formation may mean that AnxA2 phenotypes are not as
clear in the developing animal as they seem to be in culture.
The AnxA2 mouse is also eﬀectively an S100A10 knockout
animal as AnxA2 serves to prevent S100A10 degradation
in the cytoplasm. Overexpression of AnxA2 (as is seen in
some cancers) or nonstoichiometric changes in the relative
concentrations of AnxA2 and S100A10may havemore severe
phenotypes than loss of both.
There are still a number of important gaps in the AnxA2
story, such as a lack of AnxA2 crystal structure in complex
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with either actin or PI(4,5)P2 or how phosphorylation of the
protein (e.g., by Src) or PI(4,5)P2 binding precisely aﬀects its
actin remodeling activity and membrane dynamics. We can
hope that further research will throw more light on the role
of this vital cellular component.
As a final note, alterations in AnxA2 expression or
activity have been demonstrated in many diﬀerent cancers,
particularly those of the prostate, the breast, the liver, the
lung (there are too many references to cite meaningfully
here), and in the formation of infective HIV particles [29,
30]. Exactly what the protein is doing in these contexts is
a subject of much speculation; but given the importance of
endocytic traﬃcking and cell polarization in these diseases,
it is likely that some of the factors described above will
contribute to this role.
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